Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 14, 2019 | D&D Pharmatech | $137.1M Series B | Octave Life Sciences, Smilegate Investment | InterVest, LB Investment, Magna Investment |
| Jul 18, 2018 | Neuraly | $36.0M Series A | D&D Pharmatech | Dongkoo Bio&Pharma, Geon Investment, Junghee Lim, LB Investment, Keele Park, Phillip Jung, John Ku |